Hospital OCA/Monterrey International Research Center (MIRC) is a clinical research hospital base unit established in 2004 as part of the hospital efforts to conduct specialized research in Monterrey City and the Northern Mexico region, incorporating inpatient and outpatient trials and covering a wide range of therapeutic areas and indications. MIRC, as a research management group, specializes in conducting Phase I through IV clinical trials involving Pharmaceutical, Biological and Medical Device products, and it’s committed to provide a leadership and management expertise necessary to generate consistent quality data for every study performed by our center. We contract with pharmaceutical, biotechnological companies (Sponsors) and Contract Research Organizations (CROs) to coordinate and manage clinical studies throughout our network of clinical Investigator sites in the region.

MIRC, as part of the international research collaboration, is dedicated to the integrity of the research process developing advances or innovative solutions for patient care through clinical research. We provide centralized resource to our network of investigators and assist them in organize all study specific plan for each protocol execution. Additionally, we help out developing and implementing patient recruitment strategies to recruit, screen, schedule, and follow up patients throughout each study; and also providing training to investigators and their staff in the most current GCP guidelines and study protocol. Our centralized management and planner functions produce streamlined and rapid start-up capabilities that allow us to respond quickly and efficiently to the pharmaceutical and biotechnology research needs. Because we are a network of investigators, our clients only have to deal with one contract through MIRC when involving multiple investigators/sites in studies. Our research unit operates under the policies of our Procedure Manual (SOPs), local regulations, ICH-GCP Guidelines and FDA regulations (CFR). Therefore, our quality assurance plan is to ensure that MIRC complies with all regulations that our Sponsors receive accurate, objective, and timely clinical data to support their drug or device development.

MIRC also provides study management services for those Investigators that receive study grants and need professional assistance to help develop budgets, handle all regulatory processes and coordinate all study activities through our central office in Monterrey, Mexico and by:

Interacting with numerous pharmaceutical and contract research organizations.
Reviewing each trial proposal through our weekly Protocol Review group (Medical Director and representatives from Study Recruitment, Contract and Financial Services, Clinical Services, and Patient Recruitment).
Access multiple sites through one central organization.

Assist the pharmaceutical and biotechnological industry in the discovery of new medical treatments through the conduct and management of clinical trials in human subjects.